Literature DB >> 20031646

Do hemochromatosis mutations protect against iron-mediated atherogenesis?

Jerome L Sullivan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20031646     DOI： 10.1161/CIRCGENETICS.109.906230

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN： 1942-3268


× No keyword cloud information.
  15 in total

1.  Disordered vascular compliance in haemochromatosis.

Authors:  W J Cash; S O'Neill; M E O'Donnell; D R McCance; I S Young; J McEneny; I S Cadden; Neil I McDougall; M E Callender
Journal:  Ir J Med Sci       Date:  2013-09-03       Impact factor: 1.568

2.  Testing the iron hypothesis in a mouse model of atherosclerosis.

Authors:  Léon Kautz; Victoria Gabayan; Xuping Wang; Judy Wu; James Onwuzurike; Grace Jung; Bo Qiao; Aldons J Lusis; Tomas Ganz; Elizabeta Nemeth
Journal:  Cell Rep       Date:  2013-12-05       Impact factor: 9.423

Review 3.  The role of hepcidin and iron homeostasis in atherosclerosis.

Authors:  Florian Wunderer; Lisa Traeger; Haakon H Sigurslid; Patrick Meybohm; Donald B Bloch; Rajeev Malhotra
Journal:  Pharmacol Res       Date:  2020-01-25       Impact factor: 7.658

Review 4.  Safety of intravenous iron in hemodialysis patients.

Authors:  Xiaojuan Li; Abhijit V Kshirsagar; M Alan Brookhart
Journal:  Hemodial Int       Date:  2017-04-03       Impact factor: 1.812

5.  The statin-iron nexus: anti-inflammatory intervention for arterial disease prevention.

Authors:  Leo R Zacharski; Ralph G DePalma; Galina Shamayeva; Bruce K Chow
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

6.  Effects of serial phlebotomy on vascular endothelial function: Results of a prospective double-blind randomized study.

Authors:  Qurat-Ul-Ain Jelani; Bhisham Harchandani; Ritchard G Cable; Yu Guo; Hua Zhong; Timothy Hilbert; Jonathan D Newman; Stuart D Katz
Journal:  Cardiovasc Ther       Date:  2018-11-13       Impact factor: 3.023

Review 7.  Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology.

Authors:  Driton Vela
Journal:  Lab Invest       Date:  2017-10-23       Impact factor: 5.662

Review 8.  Targeting iron metabolism in drug discovery and delivery.

Authors:  Bart J Crielaard; Twan Lammers; Stefano Rivella
Journal:  Nat Rev Drug Discov       Date:  2017-02-03       Impact factor: 84.694

Review 9.  Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.

Authors:  Cédric Delporte; Pierre Van Antwerpen; Luc Vanhamme; Thierry Roumeguère; Karim Zouaoui Boudjeltia
Journal:  Mediators Inflamm       Date:  2013-07-24       Impact factor: 4.711

10.  Iron and hepcidin as risk factors in atherosclerosis: what do the genes say?

Authors:  Tessel E Galesloot; Luc L Janss; Stephen Burgess; Lambertus A L M Kiemeney; Martin den Heijer; Jacqueline de Graaf; Suzanne Holewijn; Beben Benyamin; John B Whitfield; Dorine W Swinkels; Sita H Vermeulen
Journal:  BMC Genet       Date:  2015-07-11       Impact factor: 2.797
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.